Check Cap Ltd (NASDAQ:CHEK) traded down 9.6% on Thursday . The company traded as low as $0.61 and last traded at $0.57, 51,966 shares were traded during mid-day trading. A decline of 97% from the average session volume of 1,518,305 shares. The stock had previously closed at $0.63.
A number of equities research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Check Cap from a “buy” rating to a “hold” rating in a research report on Wednesday, May 27th. HC Wainwright restated a “buy” rating and set a $2.00 price objective on shares of Check Cap in a research report on Thursday, May 28th.
The firm’s fifty day moving average price is $0.54 and its 200-day moving average price is $1.29. The company has a market capitalization of $6.94 million and a price-to-earnings ratio of -0.39.
Check Cap (NASDAQ:CHEK) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.02. Analysts forecast that Check Cap Ltd will post -0.95 EPS for the current year.
Check Cap Company Profile (NASDAQ:CHEK)
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface.
Further Reading: What is the Bid-Ask Spread?
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.